Half-year report · Q2
3001.TEDINET S100WIM3
Period2025-01-01 → 2025-06-30
Filed2025-08-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥20.8bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥39.4bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥19.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Operating income | ¥3.2bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | ¥2.1bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥3.9bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥5.5bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.9bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥5.1bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.7bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.5bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.6bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | ¥1.9bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥137.1bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥140.8bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥138.6bn | at 2024-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥48.0bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥51.1bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥89.1bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥89.7bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥90.0bn | at 2024-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥30.8bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥30.4bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.8bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.2bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.1bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥5.1bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥802m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.2bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥4.3bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥6.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥110.26 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥107.72 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.76 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 62.8% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.1% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.3% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥1.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥1.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥214m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥82m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥235m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥235m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥499m |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥4.8bn |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥4.8bn |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥641m |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥5.6bn |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥5.6bn |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥447m |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥5.7bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥5.7bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥19m |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥2.2bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1m |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥332m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥21.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥20.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥235m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥3.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-06-30 | ¥1.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-06-30 | ¥1.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥186m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | ¥94m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥202m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥202m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥590m |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.4bn |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.4bn |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥0 |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥6.1bn |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥6.1bn |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥33m |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥5.5bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥5.5bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥14m |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥2.3bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1m |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥364m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥19.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥19.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥202m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥2.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 549
| Item | Context | Value | Unit |
|---|---|---|---|
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 3301000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 1571000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 10837000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 9214000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 14139000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 10786000000 | JPY |
| Sales related expenses sga | Prior1YTDDuration | 373000000 | JPY |
| Sales related expenses sga | CurrentYTDDuration | 309000000 | JPY |
| Advertising expenses sga | Prior1YTDDuration | 306000000 | JPY |
| Advertising expenses sga | CurrentYTDDuration | 313000000 | JPY |
| Salaries and allowances oecna | Prior1YTDDuration | 1567000000 | JPY |
| Salaries and allowances oecna | CurrentYTDDuration | 1252000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 132000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 134000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | -72000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | -171000000 | JPY |
| Welfare expenses sga | Prior1YTDDuration | 304000000 | JPY |
| Welfare expenses sga | CurrentYTDDuration | 271000000 | JPY |
| Depreciation sga | Prior1YTDDuration | 123000000 | JPY |
| Depreciation sga | CurrentYTDDuration | 101000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 1223000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 863000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00524-000RealEstateBusinessReportableSegmentsMember | 5484000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | 6066000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00524-000MachineryBusinessReportableSegmentsMember | 3398000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00524-000TextilesBusinessReportableSegmentsMember | 3294000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1407000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 19651000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 19651000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00524-000RealEstateBusinessReportableSegmentsMember | 14000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00524-000MachineryBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00524-000TextilesBusinessReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 186000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 202000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -202000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00524-000RealEstateBusinessReportableSegmentsMember | 5498000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | 6066000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00524-000MachineryBusinessReportableSegmentsMember | 3398000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00524-000TextilesBusinessReportableSegmentsMember | 3295000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1594000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 19853000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -202000000 | JPY |
| Net sales | Prior1YTDDuration | 19651000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00524-000RealEstateBusinessReportableSegmentsMember | 2276000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | -33000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00524-000MachineryBusinessReportableSegmentsMember | -0 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00524-000TextilesBusinessReportableSegmentsMember | 364000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |